Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2554-2558

  Bostom, Andrew G ^a,d   Shemin, Douglas ^b   Verhoef, Petra ^c   Nadeau, Marie R ^a   Jacques, Paul F ^a   Selhub, Jacob ^a   Dworkin, Lance ^b   Rosenberg, Irwin H ^a  

^a TUFTS UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

Arteriosclerosis; End stage renal disease; Hyperhomocysteinemia; Longitudinal study

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AORTA DISEASE; ARTERIOSCLEROSIS; ARTERY DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIALYSIS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

EID: 0031471941     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2554     Document Type: Article

References (16)

1. Excerpts from the United States renal data system, United States renal data system 1995 annual report. Am J Kidney Dis. 1995; 26(suppl. 2):S85-S94.
2. Churchill DN. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients. Kidney Int. 1993;43(suppl):S16-S22.
3. Lemmers MJ, Barry JM. Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients. Diabetes Care. 1991;14:295-301.
4. Kasiske BL, Guijarro C, Massy Z, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7:158-165.
5. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7: 198-207.
6. Owen WF, Lew NL, Liu SM, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329: 1001-1006.
7. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis. 1992; 19:505-513.
8. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol. 1987;59: 91G-94G.
9. Rostand SG, Kirk KA, Rutsky EA. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int. 1982;22:304-308.
10. Cressman MD, Heyka RJ, Paganini EP, O'Neill J, Skibinski CI, Hoff HF. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation. 1992;86: 475-482.
11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Kidney Int. 1996;49:1379-1385.
12. Bostom AG, Shemin D, Lapane KL, Sutherland P, Nadeau MR, Wilson PWF, Yoburn D, Bausserman L, Tofler G, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia, hyperfibrinogeneniia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis. 1996;125: 91-101.
13. McCully KS. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
14. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullman D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
15. Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, et al. Hyperhomocyst(e)inemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 1993;43:(suppl 41):S72-S77.
16. Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Langer K, et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol. 1995;6:121-125.